TRICS III: Restrictive Transfusion Was Noninferior to Liberal Use in Patients Who Undergo Cardiac Surgery

A large study conducted in 19 countries has found that a policy of restrictive red-cell transfusion during cardiac surgery is just as safe and effective as more liberal policies.

TRICS III: la transfusión restrictiva resultó no inferior a la liberal en pacientes que reciben cirugía cardíaca

TRICS III enrolled 5243 patients and was presented at the American Heart Association (AHA) Scientific Sessions and published simultaneously in the New England Journal of Medicine (NEJM). Patients were randomized to a restrictive protocol (start transfusion if hemoglobin levels <7.5 g/dL, starting at the time of anesthesia induction) or a liberal protocol (start at hemoglobin <9.5 g/dL in the operating room or <8.5 g/dL in the recovery ward).


Read also: Study Confirms Lead Shields Protect Cath Lab Staff from Radiation Exposure”.


The primary composite endpoint (death, infarction, renal failure requiring dialysis, or stroke) was reached by 11.4% of patients in the restrictive group vs. 12.5% in the liberal group.

 

Secondary endpoints such as ICU length of stay, infection, ventilation days, and acute renal failure, among others, were no different between strategies either.


Read also: Though on the Rise, the Transradial Approach to Primary PCI Remains Underused”.


TRICS III provides evidence that a restrictive red-cell transfusion strategy is effective and safe.

 

Original title: Restrictive Liberal Red-Cell Transfusion for Cardiac Surgery.

Reference: Mazer CD et al. N Engl J Med. 2017;Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....